HIF1A and brain ischemia: Administration of deferrioxamine (an iron chelator), both in vivo and in vitro, has been found to promote the expression of HIF-1α and EPO, thus improving the tolerance against cerebral ischemia, increasing neuronal viability, and exerting protective effects on OGD-cultured neurons and MCAO rats (38).